Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 144

1.

Fulminant corticobasal degeneration: a distinct variant with predominant neuronal tau aggregates.

Ling H, Gelpi E, Davey K, Jaunmuktane Z, Mok KY, Jabbari E, Simone R, R'Bibo L, Brandner S, Ellis MJ, Attems J, Mann D, Halliday GM, Al-Sarraj S, Hedreen J, Ironside JW, Kovacs GG, Kovari E, Love S, Vonsattel JPG, Allinson KSJ, Hansen D, Bradshaw T, Setó-Salvia N, Wray S, de Silva R, Morris HR, Warner TT, Hardy J, Holton JL, Revesz T.

Acta Neuropathol. 2020 Jan 16. doi: 10.1007/s00401-019-02119-4. [Epub ahead of print]

PMID:
31950334
2.

Investigation of somatic CNVs in brains of synucleinopathy cases using targeted SNCA analysis and single cell sequencing.

Perez-Rodriguez D, Kalyva M, Leija-Salazar M, Lashley T, Tarabichi M, Chelban V, Gentleman S, Schottlaender L, Franklin H, Vasmatzis G, Houlden H, Schapira AHV, Warner TT, Holton JL, Jaunmuktane Z, Proukakis C.

Acta Neuropathol Commun. 2019 Dec 23;7(1):219. doi: 10.1186/s40478-019-0873-5.

3.

Diagnosis Across the Spectrum of Progressive Supranuclear Palsy and Corticobasal Syndrome.

Jabbari E, Holland N, Chelban V, Jones PS, Lamb R, Rawlinson C, Guo T, Costantini AA, Tan MMX, Heslegrave AJ, Roncaroli F, Klein JC, Ansorge O, Allinson KSJ, Jaunmuktane Z, Holton JL, Revesz T, Warner TT, Lees AJ, Zetterberg H, Russell LL, Bocchetta M, Rohrer JD, Williams NM, Grosset DG, Burn DJ, Pavese N, Gerhard A, Kobylecki C, Leigh PN, Church A, Hu MTM, Woodside J, Houlden H, Rowe JB, Morris HR.

JAMA Neurol. 2019 Dec 20. doi: 10.1001/jamaneurol.2019.4347. [Epub ahead of print]

PMID:
31860007
4.

Early presentation of urinary retention in multiple system atrophy: can the disease begin in the sacral spinal cord?

Panicker JN, Simeoni S, Miki Y, Batla A, Iodice V, Holton JL, Sakakibara R, Warner TT.

J Neurol. 2019 Nov 12. doi: 10.1007/s00415-019-09597-2. [Epub ahead of print]

PMID:
31720822
5.

Lower nucleus accumbens α-synuclein load and D3 receptor levels in Parkinson's disease with impulsive compulsive behaviours.

Barbosa P, Hapuarachchi B, Djamshidian A, Strand K, Lees AJ, de Silva R, Holton JL, Warner TT.

Brain. 2019 Nov 1;142(11):3580-3591. doi: 10.1093/brain/awz298.

PMID:
31603207
6.

White matter DNA methylation profiling reveals deregulation of HIP1, LMAN2, MOBP, and other loci in multiple system atrophy.

Bettencourt C, Foti SC, Miki Y, Botia J, Chatterjee A, Warner TT, Revesz T, Lashley T, Balazs R, Viré E, Holton JL.

Acta Neuropathol. 2020 Jan;139(1):135-156. doi: 10.1007/s00401-019-02074-0. Epub 2019 Sep 18.

7.

Hereditary spastic paraplegia: from diagnosis to emerging therapeutic approaches.

Shribman S, Reid E, Crosby AH, Houlden H, Warner TT.

Lancet Neurol. 2019 Dec;18(12):1136-1146. doi: 10.1016/S1474-4422(19)30235-2. Epub 2019 Jul 31. Review.

PMID:
31377012
8.

The genetic and clinico-pathological profile of early-onset progressive supranuclear palsy.

Jabbari E, Woodside J, Tan MMX, Pavese N, Bandmann O, Ghosh BCP, Massey LA, Capps E, Warner TT, Lees AJ, Revesz T, Holton JL, Williams NM, Grosset DG, Morris HR.

Mov Disord. 2019 Sep;34(9):1307-1314. doi: 10.1002/mds.27786. Epub 2019 Jul 12.

9.

Saccadic Direction Errors are Associated with Impulsive Compulsive Behaviours in Parkinson's Disease Patients.

Barbosa P, Kaski D, Castro P, Lees AJ, Warner TT, Djamshidian A.

J Parkinsons Dis. 2019;9(3):625-630. doi: 10.3233/JPD-181460.

PMID:
31282422
10.

Clinical presentations of Wilson disease.

Shribman S, Warner TT, Dooley JS.

Ann Transl Med. 2019 Apr;7(Suppl 2):S60. doi: 10.21037/atm.2019.04.27. Review.

11.

Training in neurology: lessons learnt.

Shribman S, Alexander SK, Zarkali A, Warner TT, Pereira AC, Hughes TAT, Mummery CJ.

Pract Neurol. 2019 Oct;19(5):431-437. doi: 10.1136/practneurol-2018-002129. Epub 2019 May 13.

PMID:
31085719
12.

Neuropathological progression of clinical Parkinson disease subtypes.

De Pablo-Fernández E, Lees AJ, Holton JL, Warner TT.

Nat Rev Neurol. 2019 Jun;15(6):361. doi: 10.1038/s41582-019-0197-x. No abstract available.

PMID:
31048772
13.

Review: Clinical, neuropathological and genetic features of Lewy body dementias.

Hansen D, Ling H, Lashley T, Holton JL, Warner TT.

Neuropathol Appl Neurobiol. 2019 Dec;45(7):635-654. doi: 10.1111/nan.12554. Epub 2019 May 20. Review.

PMID:
30977926
14.

Copy number variation of LINGO1 in familial dystonic tremor.

Alakbarzade V, Iype T, Chioza BA, Singh R, Harlalka GV, Hardy H, Sreekantan-Nair A, Proukakis C, Peall K, Clark LN, Caswell R, Lango Allen H, Wakeling M, Chilton JK, Baple EL, Louis ED, Warner TT, Crosby AH.

Neurol Genet. 2019 Feb 4;5(1):e307. doi: 10.1212/NXG.0000000000000307. eCollection 2019 Feb.

15.

The long-term outcome of impulsive compulsive behaviours in Parkinson's disease.

Barbosa PM, Djamshidian A, O'Sullivan SS, de Pablo-Fernandez E, Korlipara P, Morris HR, Bhatia KP, Limousin P, Foltynie T, Lees AJ, Warner TT.

J Neurol Neurosurg Psychiatry. 2019 Nov;90(11):1288-1289. doi: 10.1136/jnnp-2018-319891. Epub 2019 Feb 1. No abstract available.

PMID:
30709896
16.

Prognosis and Neuropathologic Correlation of Clinical Subtypes of Parkinson Disease.

De Pablo-Fernández E, Lees AJ, Holton JL, Warner TT.

JAMA Neurol. 2019 Apr 1;76(4):470-479. doi: 10.1001/jamaneurol.2018.4377.

17.

Association of autonomic symptoms with disease progression and survival in progressive supranuclear palsy.

Oliveira MCB, Ling H, Lees AJ, Holton JL, De Pablo-Fernandez E, Warner TT.

J Neurol Neurosurg Psychiatry. 2019 May;90(5):555-561. doi: 10.1136/jnnp-2018-319374. Epub 2018 Dec 31.

PMID:
30598430
18.

Reply to: Young- onset multiple system atrophy.

Batla A, De Pablo-Fernandez E, Erro R, Reich M, Calandra-Buonaura G, Barbosa P, Balint B, Ling H, Islam S, Cortelli P, Volkmann J, Quinn N, Holton JL, Warner TT, Bhatia KP.

Mov Disord. 2018 Dec;33(12):1975-1976. doi: 10.1002/mds.27572. No abstract available.

PMID:
30578697
19.

Neuropathology of Circadian Alterations in Parkinson Disease-Reply.

De Pablo-Fernández E, Warner TT, Holton JL.

JAMA Neurol. 2019 Jan 1;76(1):115-116. doi: 10.1001/jamaneurol.2018.3758. No abstract available.

PMID:
30508142
20.

The Outcome of Dopamine Dysregulation Syndrome in Parkinson's Disease: A Retrospective Postmortem Study.

Barbosa P, Djamshidian A, Lees AJ, Warner TT.

Mov Disord Clin Pract. 2018 Oct 4;5(5):519-522. doi: 10.1002/mdc3.12671. eCollection 2018 Sep-Oct.

21.

Dystonia.

Barbosa P, Warner TT.

Handb Clin Neurol. 2018;159:229-236. doi: 10.1016/B978-0-444-63916-5.00014-8. Review.

PMID:
30482316
22.

Delineating cerebellar mechanisms in DYT11 myoclonus-dystonia.

Sadnicka A, Galea JM, Chen JC, Warner TT, Bhatia KP, Rothwell JC, Edwards MJ.

Mov Disord. 2018 Dec;33(12):1956-1961. doi: 10.1002/mds.27517. Epub 2018 Oct 17.

PMID:
30334277
23.

Verbal adynamia in parkinsonian syndromes: behavioral correlates and neuroanatomical substrate.

Magdalinou NK, Golden HL, Nicholas JM, Witoonpanich P, Mummery CJ, Morris HR, Djamshidian A, Warner TT, Warrington EK, Lees AJ, Warren JD.

Neurocase. 2018 Aug;24(4):204-212. doi: 10.1080/13554794.2018.1527368. Epub 2018 Oct 6.

24.

Young-onset multiple system atrophy: Clinical and pathological features.

Batla A, De Pablo-Fernandez E, Erro R, Reich M, Calandra-Buonaura G, Barbosa P, Balint B, Ling H, Islam S, Cortelli P, Volkmann J, Quinn N, Holton JL, Warner TT, Bhatia KP.

Mov Disord. 2018 Jul;33(7):1099-1107. doi: 10.1002/mds.27450.

PMID:
30153390
25.

Variation at the TRIM11 locus modifies progressive supranuclear palsy phenotype.

Jabbari E, Woodside J, Tan MMX, Shoai M, Pittman A, Ferrari R, Mok KY, Zhang D, Reynolds RH, de Silva R, Grimm MJ, Respondek G, Müller U, Al-Sarraj S, Gentleman SM, Lees AJ, Warner TT, Hardy J, Revesz T, Höglinger GU, Holton JL, Ryten M, Morris HR.

Ann Neurol. 2018 Oct;84(4):485-496. doi: 10.1002/ana.25308. Epub 2018 Sep 15.

26.

Analysis of macroautophagy related proteins in G2019S LRRK2 Parkinson's disease brains with Lewy body pathology.

Mamais A, Manzoni C, Nazish I, Arber C, Sonustun B, Wray S, Warner TT, Cookson MR, Lewis PA, Bandopadhyay R.

Brain Res. 2018 Dec 15;1701:75-84. doi: 10.1016/j.brainres.2018.07.023. Epub 2018 Jul 25.

27.

Association between diabetes and subsequent Parkinson disease: A record-linkage cohort study.

De Pablo-Fernandez E, Goldacre R, Pakpoor J, Noyce AJ, Warner TT.

Neurology. 2018 Jul 10;91(2):e139-e142. doi: 10.1212/WNL.0000000000005771. Epub 2018 Jun 13.

PMID:
29898968
28.

Sensitivity and Specificity of the ECAS in Parkinson's Disease and Progressive Supranuclear Palsy.

Foley JA, Niven EH, Paget A, Bhatia KP, Farmer SF, Jarman PR, Limousin P, Warner TT, Morris HR, Bak TH, Abrahams S, Cipolotti L.

Parkinsons Dis. 2018 May 9;2018:2426012. doi: 10.1155/2018/2426012. eCollection 2018.

29.

Autonomic Dysfunction in Parkinson's Disease: The Hidden Game Changer?

De Pablo-Fernandez E, Warner TT.

Mov Disord. 2018 Jul;33(6):1028. doi: 10.1002/mds.27422. Epub 2018 May 14. No abstract available.

PMID:
29756259
30.

A Histologic Study of the Circadian System in Parkinson Disease, Multiple System Atrophy, and Progressive Supranuclear Palsy.

De Pablo-Fernández E, Courtney R, Warner TT, Holton JL.

JAMA Neurol. 2018 Aug 1;75(8):1008-1012. doi: 10.1001/jamaneurol.2018.0640.

31.

Phenotypes, genotypes, and the management of paroxysmal movement disorders.

Silveira-Moriyama L, Kovac S, Kurian MA, Houlden H, Lees AJ, Walker MC, Roze E, Paciorkowski AR, Mink JW, Warner TT.

Dev Med Child Neurol. 2018 Jun;60(6):559-565. doi: 10.1111/dmcn.13744. Epub 2018 Mar 30. Review.

32.

No evidence of iatrogenic human transmission in autopsy confirmed multiple system atrophy.

De Pablo-Fernandez E, Cerdán Santacruz D, Warner TT, Holton JL.

Mov Disord. 2018 Jul;33(7):1183-1184. doi: 10.1002/mds.27370. Epub 2018 Mar 23. No abstract available.

PMID:
29570847
33.

Dopamine reuptake transporter-single-photon emission computed tomography and transcranial sonography as imaging markers of prediagnostic Parkinson's disease.

Noyce AJ, Dickson J, Rees RN, Bestwick JP, Isaias IU, Politis M, Giovannoni G, Warner TT, Lees AJ, Schrag A.

Mov Disord. 2018 Mar;33(3):478-482. doi: 10.1002/mds.27282. Epub 2018 Jan 30.

PMID:
29380907
34.

Compulsive sexual behaviour in Parkinson's disease is associated with higher doses of levodopa.

Barbosa PM, Grippe T, Lees AJ, O'Sullivan S, Djamshidian A, Warner TT.

J Neurol Neurosurg Psychiatry. 2018 Oct;89(10):1121-1123. doi: 10.1136/jnnp-2017-317298. Epub 2017 Nov 24. No abstract available.

PMID:
29175897
35.

The neuropsychological profile of Othello syndrome in Parkinson's disease.

Foley JA, Warner TT, Cipolotti L.

Cortex. 2017 Nov;96:158-160. doi: 10.1016/j.cortex.2017.08.009. Epub 2017 Aug 16. No abstract available.

PMID:
28917380
36.

Dystonia.

De Pablo-Fernandez E, Warner TT.

Br Med Bull. 2017 Sep 1;123(1):91-102. doi: 10.1093/bmb/ldx019. Review.

PMID:
28910989
37.

Exenatide once weekly versus placebo in Parkinson's disease: a randomised, double-blind, placebo-controlled trial.

Athauda D, Maclagan K, Skene SS, Bajwa-Joseph M, Letchford D, Chowdhury K, Hibbert S, Budnik N, Zampedri L, Dickson J, Li Y, Aviles-Olmos I, Warner TT, Limousin P, Lees AJ, Greig NH, Tebbs S, Foltynie T.

Lancet. 2017 Oct 7;390(10103):1664-1675. doi: 10.1016/S0140-6736(17)31585-4. Epub 2017 Aug 3.

38.

Iatrogenic B12-deficient peripheral neuropathy following nitrous oxide administration for functional tonic leg spasm: A case report.

Kaski D, Kumar P, Murphy E, Warner TT.

Clin Neurol Neurosurg. 2017 Sep;160:108-110. doi: 10.1016/j.clineuro.2017.07.006. Epub 2017 Jul 6. No abstract available.

PMID:
28709008
39.

Association of Autonomic Dysfunction With Disease Progression and Survival in Parkinson Disease.

De Pablo-Fernandez E, Tur C, Revesz T, Lees AJ, Holton JL, Warner TT.

JAMA Neurol. 2017 Aug 1;74(8):970-976. doi: 10.1001/jamaneurol.2017.1125.

40.

Nomenclature of genetic movement disorders: Recommendations of the International Parkinson and Movement Disorder Society task force.

Marras C, Lang A, van de Warrenburg BP, Sue CM, Tabrizi SJ, Bertram L, Mercimek-Mahmutoglu S, Ebrahimi-Fakhari D, Warner TT, Durr A, Assmann B, Lohmann K, Kostic V, Klein C.

Mov Disord. 2017 May;32(5):724-725. doi: 10.1002/mds.27045. No abstract available.

PMID:
28513081
41.

Identification of candidate cerebrospinal fluid biomarkers in parkinsonism using quantitative proteomics.

Magdalinou NK, Noyce AJ, Pinto R, Lindstrom E, Holmén-Larsson J, Holtta M, Blennow K, Morris HR, Skillbäck T, Warner TT, Lees AJ, Pike I, Ward M, Zetterberg H, Gobom J.

Parkinsonism Relat Disord. 2017 Apr;37:65-71. doi: 10.1016/j.parkreldis.2017.01.016. Epub 2017 Jan 31.

PMID:
28214264
42.

Hypothalamic α-synuclein and its relation to weight loss and autonomic symptoms in Parkinson's disease.

De Pablo-Fernandez E, Courtney R, Holton JL, Warner TT.

Mov Disord. 2017 Feb;32(2):296-298. doi: 10.1002/mds.26868. Epub 2016 Nov 28. No abstract available.

PMID:
27892607
43.

Neuroendocrine abnormalities in Parkinson's disease.

De Pablo-Fernández E, Breen DP, Bouloux PM, Barker RA, Foltynie T, Warner TT.

J Neurol Neurosurg Psychiatry. 2017 Feb;88(2):176-185. doi: 10.1136/jnnp-2016-314601. Epub 2016 Oct 31. Review.

PMID:
27799297
44.

Astrogliopathy predominates the earliest stage of corticobasal degeneration pathology.

Ling H, Kovacs GG, Vonsattel JP, Davey K, Mok KY, Hardy J, Morris HR, Warner TT, Holton JL, Revesz T.

Brain. 2016 Dec;139(Pt 12):3237-3252. Epub 2016 Oct 25.

PMID:
27797812
45.

Reply letter to Jinnah "Locus pocus" and Albanese "Complex dystonia is not a category in the new 2013 consensus classification": Necessary evolution, no magic!

Klein C, Lang A, van de Warrenburg BP, Sue CM, Tabrizi SJ, Bertram L, Mercimek-Mahmutoglu S, Ebrahimi-Fakhari D, Warner TT, Durr A, Assmann B, Kostic V, Lohmann K, Marras C; International Parkinson and Movement Disorder Society Task Force on Classification and Nomenclature of Genetic Movement Disorders.

Mov Disord. 2016 Nov;31(11):1760-1762. doi: 10.1002/mds.26763. Epub 2016 Sep 13. No abstract available.

PMID:
27619077
46.

A Retrospective Evaluation of the Frequency of Impulsive Compulsive Behaviors in Parkinson's Disease Patients Treated with Continuous Waking Day Apomorphine Pumps.

Barbosa P, Lees AJ, Magee C, Djamshidian A, Warner TT.

Mov Disord Clin Pract. 2016 Aug 11;4(3):323-328. doi: 10.1002/mdc3.12416. eCollection 2017 May-Jun.

47.

MSA-C or SCA 17? A clinicopathological case update.

Doherty KM, De Pablo-Fernandez E, Houlden H, Polke JM, Lees AJ, Warner TT, Holton JL.

Mov Disord. 2016 Oct;31(10):1582-1584. doi: 10.1002/mds.26741. No abstract available.

PMID:
27477540
48.

Nomenclature of genetic movement disorders: Recommendations of the international Parkinson and movement disorder society task force.

Marras C, Lang A, van de Warrenburg BP, Sue CM, Tabrizi SJ, Bertram L, Mercimek-Mahmutoglu S, Ebrahimi-Fakhari D, Warner TT, Durr A, Assmann B, Lohmann K, Kostic V, Klein C.

Mov Disord. 2016 Apr;31(4):436-57. doi: 10.1002/mds.26527. Review.

PMID:
27079681
49.

Deletions at 22q11.2 in idiopathic Parkinson's disease: a combined analysis of genome-wide association data.

Mok KY, Sheerin U, Simón-Sánchez J, Salaka A, Chester L, Escott-Price V, Mantripragada K, Doherty KM, Noyce AJ, Mencacci NE, Lubbe SJ; International Parkinson's Disease Genomics Consortium (IPDGC), Williams-Gray CH, Barker RA, van Dijk KD, Berendse HW, Heutink P, Corvol JC, Cormier F, Lesage S, Brice A, Brockmann K, Schulte C, Gasser T, Foltynie T, Limousin P, Morrison KE, Clarke CE, Sawcer S, Warner TT, Lees AJ, Morris HR, Nalls MA, Singleton AB, Hardy J, Abramov AY, Plagnol V, Williams NM, Wood NW.

Lancet Neurol. 2016 May;15(6):585-96. doi: 10.1016/S1474-4422(16)00071-5. Epub 2016 Mar 24.

50.

Analysis of White Adipose Tissue Gene Expression Reveals CREB1 Pathway Altered in Huntington's Disease.

McCourt AC, Parker J, Silajdžić E, Haider S, Sethi H, Tabrizi SJ, Warner TT, Björkqvist M.

J Huntingtons Dis. 2015;4(4):371-82. doi: 10.3233/JHD-150172.

PMID:
26756592

Supplemental Content

Loading ...
Support Center